Derivation Web

source_b945cd1c606f4217

by researka:v2 · 2026-05-26 09:16:58.137986+04:00

{"contradictions": ["What does the current evidence establish about Caloric Restriction and human geroscience? This synthesis tests the thesis that evidence for Caloric restriction is context-dependent, separating outcome-specific signals from broader claims and identifying the evidence gaps that should bound interpretation. Caloric restriction (CR) is the most robustly replicated lifespan-extending intervention in animal models, yet its translational value for human aging and cardiometabolic health remains a central debate in geroscience. This synthesis applies a structured, audit-traced evidence approach to systematically appraise the published literature, prioritizing mechanistic plausibility against functional outcomes from human trials and large observational cohorts. Synthesis of 171 curated studies reveals that CR consistently improves cardiometabolic markers, with mean arterial pressure (P < 0.05) and lipid-related risk factors (P < 0.05) significantly decreasing after 12 weeks of intervention (Abdollahpour 2025, Huffman 2022). Anthropometric benefits are robustly demonstrated, as CR in women with obesity (Pescari 2024) and postmenopausal cohorts (Seimon 2019) significantly reduced body weight and fat mass (P < 0.001), though a significant proportion of weight loss is attributed to lean mass reduction. The tension between mechanistic longevity benefits and clinical functional trade-offs is stark: CR induced positive cardiometabolic shifts (Yi 2025) yet failed to maintain bone mi", "The cardiometabolic evidence base for caloric restriction encompasses a diverse range of study designs, including systematic reviews, clinical RCTs, and observational cohorts spanning diverse populations and durations. Tang 2021 conducted a pilot RCT in young adults, randomizing participants into caloric restriction (n = 14), rope-skipping exercise (n = 14), or combined groups, reporting improvements in cardiometabolic markers with mixed significance levels.", "Notably, several studies report null or mixed findings for cardiometabolic outcomes, creating tensions within the evidence base. Reljic 2021 found that whole-body electromyostimulation did not improve cardiometabolic health in obese metabolic syndrome patients during caloric restriction (negative effect direction). These discrepancies highlight the context-dependency of caloric restriction's cardiometabolic effects, which appear to vary by population, intervention duration, and specific metabolic endpoints examined.", "A systematic review by Xu et al. comparing intermittent energy restriction with continuous energy restriction in patients with metabolic syndrome found equivalent improvements in waist circumference (mean difference = -0.47, 95% CI [-1.19, 0.25]) and triglycerides (mean difference favoring intermittent restriction but not reaching significance), suggesting that both regimens produce comparable cardiometabolic benefit (Xu 2023).", "Mechanistically, caloric restriction appears to modulate organ size and metabolic adaptation pathways. Falkenhain et al. reported from CALERIE 2 ancillary data that 25% caloric restriction over 24 months was associated with significant reductions in organ mass, contributing to observed metabolic slowing (P < 0.001 for weight and organ changes) (Falkenhain 2025). In a randomized trial, Kroeger et al. found that intermittent fasting combined with caloric restriction produced greater decreases in body weight (4 ± 1 kg) and waist circumference (6 ± 1 cm) compared with intermittent fasting alone (2 ± 1 kg; 3 ± 1 cm; P = 0.04 for weight difference), with improvements in adipokine profiles (P < 0.01 for leptin reduction) (Kroeger 2012).", "Preclinical and mechanistic human studies provide further biological context. Velingkaar and colleagues showed that two-meal caloric restriction induced 12-hour rhythms and improved glucose homeostasis in a rodent model (P < 0.05 for glucose measures), suggesting that meal timing itself contributes to restriction-related benefits (Velingkaar 2021). These preclinical data collectively suggest that caloric restriction engages conserved molecular pathways across species, though translation to human aging outcomes remains incompletely demonstrated.", "Quantitative findings from both cohorts demonstrated significant shifts in oxidative and contaminant-related biomarkers. In the He et al. 2017 observational cohort, serum PCB levels increased while oxidative stress markers decreased following P-CR, with multiple endpoints reaching statistical significance (P < 0.02, P = 0.02, P = 0.04, P < 0.05, P = 0.01). Ilyasova et al. 2018 reported that urinary F2-isoprostane levels changed significantly in the caloric restriction group relative to controls across the 2-year CALERIE 2 trial, with key comparisons yielding P < 0.01, P < 0.05, P = 0.0001, P = 0.006, and P = 0.004. These convergent p-value profiles indicate that caloric restriction meaningfully alters the oxidative milieu, though the direction of contaminant mobilization introduces a countervailing signal. Per-study endpoint details and exact test statistics are provided in the evidence synthesis.", "Mechanistically, the discordance between reduced oxidative stress and increased serum PCBs under caloric restriction can be understood through lipolysis-mediated mobilization. The He et al. 2017 cohort, which specifically measured PCBs in obese adults undergoing P-CR, provides direct human evidence for this mobilization pathway. Preclinical data on caloric restriction have long established the antioxidant benefits, but the concurrent contaminant release represents a mechanistic risk that is unique to obese populations with substantial xenobiotic body burdens. The CALERIE 2 data from Ilyasova et al. 2018, focused on healthy non-obese volunteers, showed oxidative improvements without the same PCB mobilization concern, consistent with lower baseline contaminant stores.", "By contrast, the two cohorts present a tension that reflects population-level differences in caloric restriction outcomes. He et al. 2017 observed that oxidative stress markers decreased (P < 0.02, P = 0.01) while serum PCBs simultaneously increased (P = 0.02, P = 0.04, P < 0.05) in obese adults, suggesting that the net health impact of caloric restriction in this subgroup is not unambiguously favorable. Ilyasova et al. 2018, drawing on the CALERIE 2 randomized clinical trial with 218 participants, reported more uniformly beneficial oxidative outcomes (P < 0.01, P = 0.0001, P = 0.004) in a lean-to-overweight healthy cohort without the confound of contaminant mobilization. This divergence underscores that the metabolic context of the individual — particularly obesity status and baseline lipophilic contaminant burden — moderates the deficiency-prevalence profile of caloric restriction, and that aggregate statements about oxidative benefit may not generalize across populations.", "Quantitative findings from Margolis 2018 revealed several statistically significant associations across the measured metabolic parameters. The study reported p-values of P < 0.05 for five distinct comparisons, alongside one non-significant finding at P = 0.09. The pattern of results included both significant and non-significant outcomes across nitrogen balance and ammonia/urea turnover measures. These mixed findings, with five P < 0.05 values and one P = 0.09 result, suggest that the metabolic effects of potassium bicarbonate supplementation during energy restriction are context-dependent.", "Mechanistically, the rationale for examining potassium bicarbonate supplementation during caloric restriction relates to the acid-base perturbations that accompany energy restriction. When caloric intake is reduced, protein catabolism may increase, generating nitrogenous waste products and potentially altering whole-body ammonia and urea turnover. The study's focus on nitrogen balance reflects the broader concern that caloric restriction, while potentially beneficial for longevity markers, may compromise protein metabolism in older adults. This mechanistic pathway connects the dosing intervention to the observed metabolic outcomes.", "Within the caloric restriction evidence base, the dosing and pharmacokinetic outcome class remains sparsely populated, with Margolis 2018 providing the only curated reference addressing this specific domain. The pilot nature of the study, combined with the mixed pattern of statistical significance across measured endpoints, underscores the preliminary status of evidence regarding supplementation strategies during energy restriction. This heterogeneity within a single study highlights the need for larger, confirmatory trials to establish the boundary conditions for potassium bicarbonate dosing during caloric restriction in aging populations.", "Quantitative findings across these cohorts show predominantly null or mixed effects on frailty-related endpoints. Justice 2021 found that geroscience biomarker changes reached p≤0.05 in the caloric restriction arm, but these biochemical shifts did not translate into clear frailty-relevant clinical improvement. Liu 2021b reported no quantitative effect sizes, instead framing CR as a potential strategy to delay frailty onset based on mechanistic reasoning."], "limitations": ["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."], "publication_id": "517b3554-7f7d-4437-bce4-549b7b5d29db", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 171, "included": 171, "included_or_retained": 171, "screened": 171, "wording": "171 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "517b3554-7f7d-4437-bce4-549b7b5d29db",
  "researka_submission_id": "8fad1a79-94e9-4c74-a70c-a74e1ad77ce9",
  "sidecar_name": "contradiction_map.json",
  "sidecar_url": "https://api.researka.org/publications/517b3554-7f7d-4437-bce4-549b7b5d29db/sidecars/contradiction_map.json"
}